Profile
Gerald J.
McDougall is currently the Director at The Multiple Myeloma Research Foundation, Inc., the Director at the Infectious Disease Research Institute, and the Director at the Conquer Cancer Foundation of the American Society of Clinical.
Previously, he served as the Director at the American Society of Clinical Oncology, Inc. and the Director at the Multiple Myeloma Research Consortium.
From 2021 to 2024, he was an Independent Director at NeuBase Therapeutics, Inc. He also worked as a Partner-Health Sciences Practice at PricewaterhouseCoopers LLP from 2014 to 2020.
Mr. McDougall completed his undergraduate degree at Northeastern University.
Gerald McDougall active positions
| Companies | Position | Start |
|---|---|---|
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Director/Board Member | - |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Director/Board Member | - |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Director/Board Member | - |
Former positions of Gerald McDougall
| Companies | Position | End |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Director/Board Member | 2024-06-25 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | 2020-01-31 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Director/Board Member | - |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development | Director/Board Member | - |
Training of Gerald McDougall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services Provides funding for research on myeloma treatment | Commercial Services |
Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium Miscellaneous Commercial ServicesCommercial Services Provides research and drug development | Commercial Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Engages in research and development of biotechnology products to control infectious diseases | Commercial Services |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders | Health Technology |
- Stock Market
- Insiders
- Gerald McDougall
















